icon
沙特阿拉伯王国政府所属的官方政府网站。
icon 周四 25 6月 2026
icon
沙特官方政府网站的域名以下列后缀结尾 gov.sa

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
政府网站使用以下协议。 HTTPS 用于加密和安全。

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
在数字政府管理局注册,编号:
20250831619
建议

Post-Authorization Safety Reporting Program of Canagliflozin-based Therapy in Patients With Type 2 Diabetes in Saudi Arabia

Post-Authorization Safety Reporting Program of Canagliflozin-based Therapy in Patients With Type 2 Diabetes in Saudi Arabia

icon 2020-07-04
عنوان الدراسة
Post-Authorization Safety Reporting Program of Canagliflozin-based Therapy in Patients With Type 2 Diabetes in Saudi Arabia
داعم الدراسة
Janssen-Cilag International NV
دواء الدراسة
canagliflozin
رقم بروتوكول الدراسة
28431754DI
حالة الدراسة
Ongoing
موقع الدراسة
Specialized Medical Center (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), International Medical Center (Jeddah), Dallah Hospital (Riyadh), Almana Hospital (Jubail), Almouasa Hospital (Qatif), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), Dr. Sulaiman Al-Habib Medical Group Rayan (Riyadh), Saudi German Hospital (Jeddah)
مرحلة الدراسة
4